Best treatments for leiomyoma
5 products may treat leiomyoma, spanning FDA drug classes such as gonadotropin releasing hormone receptor agonist. The current highest-rated option is eligard kit. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 5 drugs we list for leiomyoma, all are available as lower-cost generics, spanning classes such as gonadotropin releasing hormone receptor agonist. 1 of 5 carry a safety score of 72 out of 100. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for leiomyoma — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | Gonadotropin Releasing Hormone Receptor Agonist | Generic | $5928 | View → | |
| 2 | Not yet rated | Prescription | Emulsion | Gonadotropin Releasing Hormone Receptor Agonist | Generic | $5928 | View → | |
| 3 | Not yet rated | Prescription | Injectable | Gonadotropin Releasing Hormone Receptor Agonist | Generic | $5928 | View → | |
| 4 | Not yet rated | Prescription | Kit | Gonadotropin Releasing Hormone Receptor Agonist | Generic | $5928 | View → | |
| 5 | Not yet rated | Prescription | Kit | Gonadotropin Releasing Hormone Receptor Agonist | Generic | $5928 | View → |
Narrow by drug class
Explore the class hubs: gonadotropin releasing hormone receptor agonist
Full ranking · 5 treatments
eligard kit
PrescriptionFDA-sourced
Eligard Kit (Leuprolide Acetate) is a gonadotropin releasing hormone receptor agonist used to treat Breast Neoplasms, Endometriosis, Infertility, Leiomyoma.
Pharmacy pays
~$5928.18 /30
camcevi etm
PrescriptionFDA-sourced
Camcevi Etm (Leuprolide Mesylate) is a gonadotropin releasing hormone receptor agonist used to treat Breast Neoplasms, Endometriosis, Infertility, Leiomyoma.
Pharmacy pays
~$5928.18 /30
camcevi kit
PrescriptionFDA-sourced
Camcevi Kit (Leuprolide Mesylate) is a gonadotropin releasing hormone receptor agonist used to treat Breast Neoplasms, Endometriosis, Infertility, Leiomyoma.
Pharmacy pays
~$5928.18 /30
lupron depot
PrescriptionFDA-sourced
Lupron Depot (Leuprolide Acetate) is a gonadotropin releasing hormone receptor agonist used to treat Breast Neoplasms, Endometriosis, Infertility, Leiomyoma.
Pharmacy pays
~$5928.18 /30
lupron depot-ped kit
PrescriptionFDA-sourced
Lupron Depot-Ped Kit (Leuprolide Acetate) is a gonadotropin releasing hormone receptor agonist used to treat Breast Neoplasms, Endometriosis, Infertility, Leiomyoma.
Pharmacy pays
~$5928.18 /30
Frequently asked
- What treats leiomyoma?
- Our catalog lists 5 products that may treat leiomyoma, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is eligard kit.
- What is the best-rated treatment for leiomyoma?
- By our independent recall-safety rating — not an efficacy measure — eligard kit ranks highest among the products we list for leiomyoma. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat leiomyoma?
- Treatments for leiomyoma span FDA drug classes including gonadotropin releasing hormone receptor agonist. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status